Evaluation of a Nutritional Technology for Vitamin D Absorption
This is a prospective, 2-group crossover, randomized, double-blind study to evaluate nutrient absorption.
- EligibilityCriteria: Inclusion Criteria:  Adult participants (18-55 years of age) Body mass index (BMI) <30 kg/m2 Males and nonpregnant, nonlactating females Free of gastrointestinal disorders that my impact nutrient absorption in the small intestine, endocrine, hepatic, renal, or bone diseases  Exclusion Criteria:  Use of vitamin D or calcium supplements within 3 weeks prior to the Screening Visit. Use of a tanning booth/lamp within 3 weeks prior to the Screening Visit. Travel to sunny location within 3 weeks prior to the Screening Visit. Consumption of more than 3 alcoholic drinks per day starting 48 hours before the Screening Visit. Has an allergy or intolerance to any ingredient in the study product. Participating in another study that has not been approved as a concomitant study by Abbott Nutrition.  Use of the following medications that may have interactions with vitamin D absorption or metabolism:  Aluminum-containing phosphate binders Anticonvulsants Atorvastatin Calcipotriene Cholestyramine Cytochrome P-450 3A4 substrates Digoxin Diltiazem Orlistat Thiazide diuretics Corticosteroids Stimulant laxatives Verapamil - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 18 Years - MaximumAge: 55 Years - StdAgeList: Adult